Clinical Hematology Research Career Development Program (K12)
The summary for the Clinical Hematology Research Career Development Program (K12) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Clinical Hematology Research Career Development Program (K12): Purpose: The purpose of this Program is to develop and evaluate multidisciplinary career development programs in non-malignant hematology that will equip new investigators with the knowledge and skills to address complex problems in blood diseases. Through this Program, the NHLBI will support the early career development of clinical researchers who are expected to become independent investigators and assume academic leadership roles in non-malignant clinical hematology. To accomplish this, NHLBI invites institutions with established clinical research infrastructures and expertise in non-malignant clinical hematology to submit applications to establish Clinical Hematology Research Career Development Programs. Programs supported under this RFA should provide comprehensive, multidisciplinary training in research designs and methodologies, standard and potentially future or innovative approaches to the clinical management of patients with non-malignant hem! atologic diseases, and research opportunities in these diseases. Programs should include a core curriculum, didactics, and a short-term research project for each Scholar.
|Federal Grant Title:||Clinical Hematology Research Career Development Program (K12)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-HL-06-006|
|Type of Funding:||Grant|
|CFDA Descriptions:||Blood Diseases and Resources Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Feb 14, 2006|
|Posted Date:||Dec 05, 2005|
|Creation Date:||Dec 05, 2005|
|Archive Date:||Mar 16, 2006|
|Total Program Funding:||$2,000,000|
|Maximum Federal Grant Award:||$370,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:||5|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Private institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government are eligible to apply. Although foreign institutions are not eligible to apply, foreign collaborators may participate in this program through subcontract(s) with domestic institutions. Applicant institutions must have established clinical research infrastructures and expertise in non-malignant clinical hematology, and strong clinical research faculty with expertise in the related disciplines. . See Section III.3.Other-Specialty Eligibility Criteria.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • Perinatal Stroke (R01)
- • Selected Topics in Transfusion Medicine (R01)
- • Selected Topics in Transfusion Medicine (R21)
- • Advancing Erythroid Cell Biology (R01)
- • The Role of the Human Virome in Heart, Lung, and Blood Health and Resilience (R61/R33)
- • Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
- • Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow F...
- • Specialized Centers of Clinically Oriented Research (Sccor) in Transfusion Biology and Med...
- More Grants from the National Institutes of Health
- • BRAIN Initiative: Exploratory Targeted BRAIN Circuits Projects - eTargetedBCP (R21)
- • BRAIN Initiative: Targeted BRAIN Circuits Projects - TargetedBCP (R01)
- • Tools for Clinical Care and Management of Alzheimers Disease (AD) and its Comorbidities (R...
- • Tools for Clinical Care and Management of Alzheimers Disease (AD) and Its Comorbidities (R...
- • Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (...